GeneCentric will present three posters at the American Association for Cancer Research (AACR) Annual Meeting 2026 taking place in San Diego, California from April 17-22. The company will also participate in the Myriad Genetics Spotlight Theater (“Advances in ctDNA Testing towards Biopharma Development & Clinical Dx”) and Discovery Life Sciences Flash Talk during the meeting.

 

Myriad Genetics Spotlight Theater
Date & Time: Sunday, April 19, 3:30 – 4:30pm PT
Location: Theater B

Title: Advances in ctDNA Testing towards Biopharma Development & Clinical Dx
Speaker: Dale Muzzey, PhD, Chief Scientific Officer, Myriad Genetics

Title: Expanding liquid biopsy utility by inferring gene expression from cfDNA with ExpressCT™ fragmentomics technology
Speaker: Michael Milburn, PhD, President and CEO, GeneCentric

Poster Sessions
Date & Time: Tuesday, April 21, 9:00am – 12:00pm PT

Title: Fragmentomic analysis of cfDNA WGS at regulatory regions generates gene-level expression-like traits for subtype analysis in breast cancer
Abstract Number: 4049
Session Title: Liquid Biopsies: Circulating Nucleic Acids 4
Poster Section: 45 | Poster Board: 8
Poster Number: 5313

Title: Combining gene expression and mutation profiling in a single cfDNA assay through the addition of a custom hybrid capture panel targeting gene regulatory regions to a commercial CGP panel
Abstract Number: 7293
Session Title: Liquid Biopsies: Circulating Nucleic Acids 4
Poster Section: 45 | Poster Board: 9
Poster Number: 5314

Title: Fragmentomics analysis of targeted hybrid capture NGS cfDNA gene panel data yields an orthogonal genomic dimension for developing a robust prognostic model for metastatic breast cancer patients
Abstract Number: 3960
Session Title: Prognostic Biomarkers 3
Poster Section: 47 | Poster Board: 10
Poster Number: 5372
 

The posters will be accessible under the News & Events section of GeneCentric’s website following the conference.

Discovery Life Sciences Flash Talk
Date & Time: Tuesday, April 21, 3:30pm PT
Location: Exhibit Booth 3038

Title: Beyond mutations: rapid cfDNA assay development for quantitative gene expression and tumor phenotyping
Speaker: Jim Davison, PhD, Director, Translational Genomics, GeneCentric

 

Please reach out to us at meetings@genecentric.com  to schedule a 1:1 meeting.